Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
7.77
-0.12 (-1.52%)
Sep 2, 2026, 5:29 PM CET

Egetis Therapeutics AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,6682,1102,5151,6331,5241,108
Market Cap Growth
101.02%-16.09%54.03%7.15%37.56%-10.17%
Enterprise Value
3,3592,0562,4971,5501,335939
Last Close Price
7.895.347.005.587.106.16

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
491.1322.615.665.665.665.66
PS Ratio
55.5833.8254.5528.3467.4229.00
PB Ratio
7.626.235.102.993.012.10
P/TBV Ratio
7.646.275.143.023.042.13

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
50.8932.9654.1626.9159.0724.58

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.140.250.240.210.010.01
Net Debt / Equity Ratio
-0.64-0.39-0.47-0.35-0.25-0.26
Net Debt / EBITDA Ratio
0.810.400.730.610.641.34
Net Debt / FCF Ratio
1.030.491.030.680.721.07
Asset Turnover
0.090.090.060.090.040.06
Inventory Turnover
39.2930.3013.6516.92219.3950.34
Quick Ratio
1.461.011.833.272.803.85
Current Ratio
1.491.051.863.332.983.90
Return on Equity (ROE)
-96.92%-82.37%-66.17%-62.16%-37.51%-18.05%
Return on Assets (ROA)
-34.38%-28.82%-25.91%-29.45%-21.78%-10.22%
Return on Capital Employed (ROCE)
-78.80%-82.90%-54.70%-47.40%-38.50%-19.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.05%-16.23%-13.66%-20.02%-12.72%-9.44%
FCF Yield
-8.17%-12.65%-9.06%-17.05%-11.39%-11.76%
Buyback Yield / Dilution
-17.59%-20.10%-19.57%-33.86%-7.97%-166.96%